[{"id":"95f6d6f9-21d5-47ce-8696-ca2c222a1a8d","acronym":"CaPP3 Israel","url":"https://clinicaltrials.gov/study/NCT02497820","created_at":"2021-03-25T18:19:44.945Z","updated_at":"2024-07-02T16:37:29.546Z","phase":"Phase 3","brief_title":"Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers","source_id_and_acronym":"NCT02497820 - CaPP3 Israel","lead_sponsor":"Tel-Aviv Sourasky Medical Center","biomarkers":" MLH1 • MSH6 • MSH2 • EPCAM","pipe":" | ","alterations":" MSI-H/dMMR • MSH6 deletion","tags":["MLH1 • MSH6 • MSH2 • EPCAM"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR • MSH6 deletion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e aspirin"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 1800","initiation":"Initiation: 09/01/2016","start_date":" 09/01/2016","primary_txt":" Primary completion: 09/01/2027","primary_completion_date":" 09/01/2027","study_txt":" Completion: 09/01/2027","study_completion_date":" 09/01/2027","last_update_posted":"2016-08-25"}]